Tools and techniques to study ligand-receptor interactions and receptor activation by TNF superfamily members

Methods in Enzymology

Volumn 545, Issue , 2014, Pages 103-125

  Schneider, Pascal ^a   Willen, Laure ^a   Smulski, Cristian R ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Avidity; Cell death; Interaction; Ligand; Receptor

Indexed keywords

FAS ANTIGEN; FC RECEPTOR; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; LIGAND; PROTEOGLYCAN; SIGNAL PEPTIDE; STREPTAVIDIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; PROTEIN BINDING; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; BINDING AFFINITY; BINDING COMPETITION; CELL ASSAY; CELL LINE; CELL VIABILITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; IMMUNOPRECIPITATION; LIGAND BINDING; MEMBRANE BINDING; NUCLEOTIDE SEQUENCE; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; RECEPTOR BINDING; BIOASSAY; CELL DEATH; CHEMISTRY; GENETICS; METABOLISM; PROCEDURES;

BIOLOGICAL ASSAY; CELL DEATH; HUMANS; LIGANDS; PROTEIN BINDING; PROTEIN INTERACTION MAPS; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84905040386     PISSN: 00766879     EISSN: 15577988     Source Type: Book Series    
DOI: 10.1016/B978-0-12-801430-1.00005-6     Document Type: Chapter

References (21)

1. B.B. Aggarwal Signalling pathways of the TNF superfamily: A double-edged sword Nature Reviews. Immunology 3 2003 745 756
2. C. Banning, J. Votteler, D. Hoffmann, H. Koppensteiner, M. Warmer, and R. Reimer et al. A flow cytometry-based FRET assay to identify and analyse protein-protein interactions in living cells PLoS One 5 2010 e9344
3. S. Bhatnagar, and A. Kumar The TWEAK-Fn14 system: Breaking the silence of cytokine-induced skeletal muscle wasting Current Molecular Medicine 12 2012 3 13
4. J.L. Bodmer, P. Schneider, and J. Tschopp The molecular architecture of the TNF superfamily Trends in Biochemical Sciences 27 2002 19 26
5. C. Bossen, T.G. Cachero, A. Tardivel, K. Ingold, L. Willen, and M. Dobles et al. TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts Blood 111 2008 1004 1012
6. C. Bossen, K. Ingold, A. Tardivel, J.L. Bodmer, O. Gaide, and S. Hertig et al. Interactions of tumor necrosis factor (TNF) and TNF receptor family members in the mouse and human Journal of Biological Chemistry 281 2006 13964 13971
7. C. Bossen, A. Tardivel, L. Willen, C.A. Fletcher, M. Perroud, and F. Beermann et al. Mutation of the BAFF furin cleavage site impairs B-cell homeostasis and antibody responses European Journal of Immunology 41 2011 787 797
8. O. Gaide, and P. Schneider Permanent correction of an inherited ectodermal dysplasia with recombinant EDA Nature Medicine 9 2003 614 618
9. I.S. Grewal Overview of TNF superfamily: A chest full of potential therapeutic targets Advances in Experimental Medicine and Biology 647 2009 1 7
10. R. Hanada, T. Hanada, V. Sigl, D. Schramek, and J.M. Penninger RANKL/RANK-beyond bones Journal of Molecular Medicine (Berlin, Germany) 89 2011 647 656
11. N. Holler, A. Tardivel, M. Kovacsovics-Bankowski, S. Hertig, O. Gaide, and F. Martinon et al. Two adjacent trimeric Fas ligands are required for Fas signaling and formation of a death-inducing signaling complex Molecular and Cellular Biology 23 2003 1428 1440
12. K. Ingold, A. Zumsteg, A. Tardivel, B. Huard, Q.G. Steiner, and T.G. Cachero et al. Identification of proteoglycans as the APRIL-specific binding partners Journal of Experimental Medicine 201 2005 1375 1383
13. A.A. Lobito, T.L. Gabriel, J.P. Medema, and F.C. Kimberley Disease causing mutations in the TNF and TNFR superfamilies: Focus on molecular mechanisms driving disease Trends in Molecular Medicine 17 2011 494 505
14. M.L. Mikkola TNF superfamily in skin appendage development Cytokine & Growth Factor Reviews 19 2008 219 230
15. P. Schneider Production of recombinant TRAIL and TRAIL receptor: Fc chimeric proteins Methods in Enzymology 322 2000 322 345
16. P. Schneider The beautiful structures of BAFF, APRIL and their receptors. BLyS ligands and receptors M. Cancro, BLyS ligands and receptors 2009 Humana Press New York 1 18
17. P. Schneider, N. Holler, J.L. Bodmer, M. Hahne, K. Frei, and A. Fontana et al. Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity Journal of Experimental Medicine 187 1998 1205 1213
18. P.R. Selvin The renaissance of fluorescence resonance energy transfer Nature Structural Biology 7 2000 730 734
19. C.R. Smulski, J. Beyrath, M. Decossas, N. Chekkat, P. Wolff, and K. Estieu-Gionnet et al. Cysteine-rich domain 1 of CD40 mediates receptor self-assembly Journal of Biological Chemistry 288 2013 10914 10922
20. A. Strasser, P.J. Jost, and S. Nagata The many roles of FAS receptor signaling in the immune system Immunity 30 2009 180 192
21. L.K. Swee, K. Ingold-Salamin, A. Tardivel, L. Willen, O. Gaide, and M. Favre et al. Biological activity of ectodysplasin A is conditioned by its collagen and heparan sulfate proteoglycan-binding domains Journal of Biological Chemistry 284 2009 27567 27576